Annette Langer-Gould, MD, PhD
Los Angeles Medical Center
Dr. Annette Langer-Gould is the regional lead for Clinical and Translational Neuroscience for the Southern California Permanente Medical Group and a practicing multiple sclerosis specialist at the Kaiser Permanente Los Angeles Medical Center. Dr. Langer-Gould leads a team that develops, implements, and evaluates programs to provide high-quality, affordable care for individuals with MS and other neurologic diseases.
Dr. Langer-Gould has been studying different aspects of MS susceptibility and prognosis for over 15 years. Her epidemiologic research focuses on how the interplay between genotype and modifiable factors such as race/ethnicity, vitamin D, and sun exposure determines MS susceptibility and prognosis. In collaboration with the Swedish MS Registry, she is also studying the comparative effectiveness of rituximab and other MS treatments in a trial funded by the Patient-Centered Outcomes Research Institute. Dr. Langer-Gould currently serves as a voting member on the California Technology Assessment Forum, a core program of the Institute for Clinical and Economic Review.
Areas of Focus
- Multiple sclerosis susceptibility and prognosis
- Comparative effectiveness of treatments for MS
University of Pittsburgh School of Medicine